CliniGA CRO

CliniGA CRO Blog

ICH E8(R1): running a critical-to-quality workshop

Critical-to-quality factors are not a new name for every operational risk.

Cover image for: ICH E8(R1): running a critical-to-quality workshop
Photo: NavyMedicine · License: Public domain · Cropped and resized.
Published
Updated
Sources checked

Critical-to-quality factors are not a new name for every operational risk. The E8(R1) approach helps teams identify, during design, the conditions that matter most for protecting participants and answering the study question reliably with a proportionate operational approach.

Identify the important decision

ICH E8(R1) frames quality as fitness for purpose and supports early cross-disciplinary discussion. Bring investigator, data, statistics, safety and participant perspectives into protocol development. Discuss what each additional procedure contributes to the research objective and whether its value justifies the burden it creates.

Pair factors with failure scenarios

For example, if the primary endpoint requires measurement within a defined window, a delayed visit may be a relevant failure scenario. Record the factor, measurement method, threat and preventive control together. This produces a design-linked decision rather than an unexplained heading called data quality.

Test the workshop output

Assign a measurable early warning and decision owner to each factor. Assess whether the control itself creates participant burden or missing data. If the workshop’s output never reaches monitoring, data management and training plans, it remains a classification in meeting minutes rather than an operational safeguard.

  • Write a failure scenario for the primary endpoint.
  • Assign an early warning and decision owner to each factor.
  • Assess the control’s effect on participant burden.

Revisit factors during conduct

Reassess factors after new safety information, unexpected recruitment patterns or endpoint-measurement difficulty. A growing factor count is not a quality indicator. Record what changed, why and which control should adapt; for unchanged factors, explain why the existing approach continues to be suitable for the study.

Frequently asked questions

Is every risk a critical-to-quality factor?
No. Justify its important effect on participant protection or the reliability of results.
Is the workshop finished at study start?
Initial design matters, but factors are reassessed as new information emerges throughout conduct.

Sources

  1. FDA — ICH E8(R1) General Considerations for Clinical Studies
  2. FDA — ICH E8(R1), full guidance